5P Exploratory biomarker analysis from neoadjuvant atezolizumab, pertuzumab, trastuzumab plus docetaxel (NEO-PATH) in HER2+ early breast cancer H. K. Ahn,K. Park, S. H. Sim, K. J. Suh, M. H. Kim,W-Y. Park,Y-L. Choi,S-A. Im,K. H. Jung,Y. H. ParkAnnals of Oncology（2022）引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
